Table 3

Differences between CGM users and nonusers

Users NonuserstP value95% CI
Number of barriers reported3.25 (2.3)4.32 (2.56)t(1,301) = 8.33<0.001a0.81, 1.32
Age38.29 (14.64)33.48 (14.55)t(1,501) = −6.21<0.001a−6.34, −3.29
Diabetes duration22.89 (13.09)18.83 (11.91)t(1,045) = −5.8<0.001a−5.4, −2.71
Technology attitudes
 General26.0 (4.66)24.84 (4.39)t(1,498) = −4.86<0.001a−1.63, −0.69
 Diabetes specific22.61 (3.22)21.44 (3.46)t(1,239) = −6.54<0.001a−1.38, −0.62
Diabetes distress1.99 (0.76)2.06 (0.77)t(1,501) = 1.940.052−0.001, 0.16
HbA1c
 %7.3 (1.18)7.67 (1.42)t(435) = 2.950.003a0.11, 0.61
 mmol/mol56 (13)61 (15)
  • Data are mean (SD) unless otherwise indicated. HbA1c n = 452.

  • aTest remained significant at the 5% level, with Benjamini-Hochberg adjustment.